Moneycontrol
HomeNewsBusinessGo First's legal battle with P&W likely to be messy, drawn-out affair: Execs
Trending Topics

Go First's legal battle with P&W likely to be messy, drawn-out affair: Execs

Even if there is a resolution of the matter, P&W may not be able to supply engines for six months due to global supply chain issues, delaying Go First’s plans to resume flights

May 09, 2023 / 18:55 IST
Story continues below Advertisement

Pratt & Whitney air-cooled radial engine of U.S. aviator Amelia Earhardt's Lockheed 5B Vega aircraft is seen at Air and Space Museum in Washington

Go First, which suspended operations and filed for voluntary insolvency, may find it difficult to resume flights in India any time soon because the airline's legal battle with Pratt & Whitney over faulty engines is likely to be a messy, long drawn-out affair, senior aviation executives said.

“Pratt & Whitney is not likely to just give in to the demand of Go First and provide both compensation for the grounded fleet and also supply it with new engines or spare parts," said a senior executive of an international carrier operating in India.

Story continues below Advertisement

He added that even if Go First wins its legal battle against P&W, the engine maker is likely to contest the case in the higher courts, which could delay the resumption of Go First’s operations by up to a year.

Go First filed for insolvency on May 2, citing the grounding of half of its fleet due to faulty engines supplied by P&W. Earlier, on April 28, the airline moved an emergency petition before the Delaware Federal Court on April 28, calling for a legal order to force P&W to comply with two arbitral awards issued by the Singapore International Arbitration Centre (SIAC).

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show